VICL : Summary for Vical Incorporated - Yahoo Finance

U.S. Markets close in 34 mins.

Vical Incorporated (VICL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.31+0.01 (+0.43%)
As of 3:23 PM EST. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close2.30
Bid2.31 x 100
Ask2.37 x 100
Day's Range2.28 - 2.40
52 Week Range2.26 - 4.80
Avg. Volume44,871
Market Cap25.53M
PE Ratio (TTM)-2.58
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube29 days ago

    ETF’s with exposure to Vical, Inc. : November 7, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Vical, Inc. Here are 5 ETF’s with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vical, Inc. :VICL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016
    Capital Cubelast month

    Vical, Inc. :VICL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016

    Categories: Yahoo Finance Get free summary analysis Vical, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Vical, Inc. – Agenus Inc., Newlink Genetics Corporation, Pfizer Inc., Merck & Co., Inc. and Bristol-Myers Squibb Company (AGEN-US, NLNK-US, PFE-US, MRK-US and BMY-US) that have also reported for ... Read more (Read more...)

  • Associated Presslast month

    Vical reports 3Q loss

    The San Diego-based company said it had a loss of 24 cents per share. The drug developer posted revenue of $2.6 million in the period. The company's shares closed at $2.32. A year ago, they were trading ...